当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2013年第1期
编号:12361780
指导接受伊马替尼治疗的男性慢性髓系白血病患者成功生育1例(2)
http://www.100md.com 2013年1月5日 《中国医药导报》 2013年第1期
     综上所述,笔者认为男性CML患者接受TIK治疗期间受孕未明显增加子女畸形风险。本例成功受孕的个案带来很好的启示,随着CML患者生存质量的提供,正确指导受孕、妊娠具有重要的临床意义。

    [参考文献]

    [1] Ault P,Kantarjian H,O'Brien S,et al. Pregnancy among patients with chronic myeloid leukemia treated with imatinib [J]. Journal of Clinical Oncology,2006,24(7):1204-1208.

    [2] Pye SM,Cortes J,Ault P,et al. The effects of imatinib on pregnancy outcome [J]. Blood,2008,111(12):5505-5508.

    [3] Hensley ML,Ford JM. Imatinib treatment:Specific issues related to safety,fertility,and pregnancy [J]. Seminars in Hematology,2003,40(2):21-25.

    [4] Ramasamy KHJ,Lim Z,Mufti GJ,et al. Successful pregnancies involving men with chronic myeloid leukaemia on imatinib therapy [J]. British Journal of Haematology,2007,137(4):374-375.

    [5] Breccia M CL,Montefusco E,Frustaci A,et al. Male patients with chronic myeloid leukemia treated with imatinib involved in healthy pregnancies:report of five cases [J]. Leukemia Research,2008,32(3):519-520.

    [6] Apperley J. Issues of Imatinib and Pregnancy Outcome [J]. Journal of the National Comprehensive Cancer Network,2009,7(10):1050-1058.

    [7] Apperley J. CML in pregnancy and childhood [J]. Best Practice & Research Clinical Haematology,2009,22(3):455-474.

    [8] Nurmio M,Kallio J,Toppari J,et al. Adult reproductive functions after early postnatal inhibition by imatinib of the two receptor tyrosine kinases,c-kit and PDGFR,in the rat testis [J]. Reproductive Toxicology,2008,25(4):442-446.

    (收稿日期:2012-07-24 本文编辑:郝明明), http://www.100md.com(成玉斌等)
上一页1 2